AACR Cancer Progress Report 2016

* This author contributed to the development and review of this manuscript but is unable to endorse the request for NIH funding . It is a tremendously exciting time for the cancer community. Thanks to research, we are making significant progress against the many diseases we

[1]  R. Lew,et al.  Prevention and early detection strategies for melanoma and skin cancer. Current status. , 1996, Archives of dermatology.

[2]  A. Jemal,et al.  Where Can Colorectal Cancer Screening Interventions Have the Most Impact? , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[3]  J. Blay,et al.  Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial , 2016, The Lancet.

[4]  W. Willett,et al.  Early Life Body Fatness and Risk of Colorectal Cancer in U.S. Women and Men—Results from Two Large Cohort Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[5]  R. Gelber,et al.  Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Ravaud,et al.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.

[7]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[8]  S. Nelson,et al.  Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy , 2010, Clinical Cancer Research.

[9]  L. Crinò,et al.  Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.

[10]  Oliver N Keene,et al.  Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.

[11]  Chien-Jen Chen,et al.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.

[12]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[13]  M. Vidyasagar,et al.  Effectiveness of pranayama on cancer-related fatigue in breast cancer patients undergoing radiation therapy: A randomized controlled trial , 2015, International journal of yoga.

[14]  C. Klabunde,et al.  Vital Signs: Colorectal Cancer Screening Test Use — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.

[15]  Gail M Williams,et al.  Reduced melanoma after regular sunscreen use: randomized trial follow-up. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  W. Willett,et al.  Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study , 2016, British Medical Journal.

[17]  T. Rebbeck.  Precision Prevention of Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[18]  Office on Smoking.  How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General , 2010 .

[19]  Nicholas J Shaheen,et al.  ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.

[20]  Julia H. Rowland,et al.  Mental and Physical Health–Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[21]  Jeffrey W. Clark,et al.  Crizotinib in ROS1-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.

[22]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[23]  Thomas C Wright,et al.  Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. , 2011, The Lancet. Oncology.

[24]  Janet E. Fulton,et al.  Vital signs: walking among adults--United States, 2005 and 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[25]  S. Nass,et al.  Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology: Workshop Summary , 2016 .

[26]  D. Rein,et al.  Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[27]  E. Giovannucci,et al.  Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk , 2015, Gut.

[28]  J. Singer,et al.  Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. , 2013, JAMA.

[29]  K. Syrigos,et al.  Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial. , 2015, The Lancet. Oncology.

[30]  C. Rudin,et al.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.

[31]  Stuart L Schreiber,et al.  AACR Cancer Progress Report 2012 , 2012, Clinical Cancer Research.

[32]  S. Holmberg,et al.  Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988‐2012 , 2016, Hepatology.

[33]  Anthony Fyles,et al.  Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.

[34]  J. Maris,et al.  Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. , 2013, The Lancet. Oncology.

[35]  Use of indoor tanning devices by adults--United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[36]  James C Yao,et al.  Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study , 2016, The Lancet.

[37]  S. Michie,et al.  Gradual Versus Abrupt Smoking Cessation , 2016, Annals of Internal Medicine.

[38]  E. Mardis,et al.  AACR Cancer Progress Report 2014 , 2014, Clinical Cancer Research.

[39]  Education Welfare.,et al.  Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .

[40]  M. Chren,et al.  International prevalence of indoor tanning: a systematic review and meta-analysis. , 2014, JAMA dermatology.

[41]  J. Engelman,et al.  Ceritinib in ALK-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.

[42]  A. Giuliano,et al.  Ten-year survival results of ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node (Alliance). , 2016 .

[43]  Stephanie R. Morain,et al.  Have Tobacco 21 Laws Come of Age? , 2016, The New England journal of medicine.

[44]  J. Wolchok,et al.  Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[45]  M. Millenson,et al.  PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. , 2015, The New England journal of medicine.

[46]  M. Pishvaian,et al.  Current management of inflammatory bowel disease and colorectal cancer. , 2011, Gastrointestinal cancer research : GCR.

[47]  Y. Shentu,et al.  Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial , 2016, The Lancet.

[48]  M. Irwin,et al.  Yoga for persistent fatigue in breast cancer survivors , 2012, Cancer.

[49]  Sameer M. Siddiqi,et al.  Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.

[50]  Laura Kann,et al.  Youth risk behavior surveillance--United States, 2013. , 2014, MMWR supplements.

[51]  Marc Peeters,et al.  Randomized trial of TAS-102 for refractory metastatic colorectal cancer. , 2015, The New England journal of medicine.

[52]  M. Makary,et al.  Underreporting of Robotic Surgery Complications , 2015, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[53]  D. Teachey,et al.  T Cells Engineered With a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Produce Significant In Vivo Proliferation, Complete Responses and Long-Term Persistence Without Gvhd In Children and Adults With Relapsed, Refractory ALL , 2013 .

[54]  Pranesh P. Chowdhury,et al.  Surveillance for Certain Health Behaviors, Chronic Diseases, and Conditions, Access to Health Care, and Use of Preventive Health Services Among States and Selected Local Areas
- Behavioral Risk Factor Surveillance System, United States, 2012. , 2016, Morbidity and mortality weekly report. Surveillance summaries.

[55]  A. Hauschild,et al.  Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.

[56]  R. Bourgon,et al.  Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial , 2016, The Lancet.

[57]  Elaine R Mardis,et al.  AACR Cancer Progress Report 2013 , 2013, Clinical Cancer Research.

[58]  Rachel L. Thompson,et al.  Policy and action for cancer prevention , 2010, Perspectives in public health.

[59]  T. Skolarus,et al.  American Cancer Society prostate cancer survivorship care guidelines , 2014, CA: a cancer journal for clinicians.

[60]  A. Ziogas,et al.  Sociodemographic Disparities in Advanced Ovarian Cancer Survival and Adherence to Treatment Guidelines , 2015, Obstetrics and gynecology.

[61]  R. Pazdur,et al.  Seamless Oncology-Drug Development. , 2016, The New England journal of medicine.

[62]  G. Armstrong,et al.  Clinical ascertainment of health outcomes among adults treated for childhood cancer. , 2013, JAMA.

[63]  L. Ku,et al.  Health Care Reform and Women’s Insurance Coverage for Breast and Cervical Cancer Screening , 2012, Preventing chronic disease.

[64]  J. Lunceford,et al.  Pembrolizumab for the treatment of non-small-cell lung cancer. , 2015, The New England journal of medicine.

[65]  T. Holford,et al.  Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. , 2014, JAMA.

[66]  A. Hauschild,et al.  Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial , 2012, The Lancet.

[67]  C. Karema,et al.  Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. , 2012, Bulletin of the World Health Organization.

[68]  Robin L. Jones,et al.  Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  P. Scheet,et al.  Genomic Landscape of Colorectal Mucosa and Adenomas , 2016, Cancer Prevention Research.

[70]  R. Stupp,et al.  The Role of Radio- and Chemotherapy in Glioblastoma , 2005, Oncology Research and Treatment.

[71]  S. J. Henley,et al.  Human Papillomavirus-Associated Cancers - United States, 2008-2012. , 2016, MMWR. Morbidity and mortality weekly report.

[72]  M. Dolled-Filhart,et al.  Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) , 2014 .

[73]  P. Jänne,et al.  AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. , 2015, The New England journal of medicine.

[74]  R. Monina Klevens,et al.  The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007 , 2012, Annals of Internal Medicine.

[75]  A. Palumbo,et al.  Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma. , 2015, The New England journal of medicine.

[76]  G. Daniels,et al.  Improved median overall survival (OS) in patients with metastatic melanoma (mM) treated with high-dose (HD) IL-2: Analysis of the PROCLAIM 2007-2012 national registry. , 2014 .

[77]  Graham A. Colditz,et al.  Applying What We Know to Accelerate Cancer Prevention , 2012, Science Translational Medicine.

[78]  K. Artyushkova,et al.  Elevated Concentrations of U and Co-occurring Metals in Abandoned Mine Wastes in a Northeastern Arizona Native American Community. , 2015, Environmental science & technology.

[79]  Brigid M Lynch,et al.  Sedentary Behavior and Cancer: A Systematic Review of the Literature and Proposed Biological Mechanisms , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[80]  K. Savage,et al.  Anaplastic large cell lymphoma, ALK-positive. , 2012, Critical reviews in oncology/hematology.

[81]  Heidi Ledford.  Old cancer drug gets fresh look , 2014, Nature.

[82]  L. Presta,et al.  Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.

[83]  K. Schmitz,et al.  Weight Lifting and Physical Function Among Survivors of Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  W. Mechelen,et al.  The economic burden of physical inactivity: a global analysis of major non-communicable diseases , 2016, The Lancet.

[85]  M. Dolled-Filhart,et al.  A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV–associated head and neck (H/N) cancer. , 2014 .

[86]  P. Moore,et al.  Merkel cell carcinoma: a virus-induced human cancer. , 2012, Annual review of pathology.

[87]  Jason B. Williams,et al.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.

[88]  J. Roberts.  News of Science , 1956, Science.

[89]  B. Lushniak,et al.  The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .

[90]  J. Wolchok,et al.  Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL). , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  R. DeRubeis,et al.  Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  Kassandra I. Alcaraz,et al.  Prevalence and Correlates of Smoking and Cessation-Related Behavior among Survivors of Ten Cancers: Findings from a Nationwide Survey Nine Years after Diagnosis , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[93]  David C. Smith,et al.  Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients (pts) with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis. , 2014 .

[94]  Gail M. Williams,et al.  Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use , 2006, Cancer Epidemiology Biomarkers & Prevention.

[95]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[96]  Sanjay G. Patel,et al.  Comparison of Perioperative and Early Oncologic Outcomes between Open and Robotic Assisted Laparoscopic Prostatectomy in a Contemporary Population Based Cohort. , 2016, The Journal of urology.

[97]  G. Guy,et al.  Sunburn and sun protective behaviors among adults aged 18-29 years--United States, 2000-2010. , 2012, MMWR. Morbidity and mortality weekly report.

[98]  J. Taube,et al.  Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial. , 2014 .

[99]  W. Maziak,et al.  Waterpipe tobacco smoking: an emerging health crisis in the United States. , 2010, American journal of health behavior.

[100]  C. Schumann,et al.  Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. , 2015, The Lancet. Oncology.

[101]  Peter Boyle,et al.  Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[102]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[103]  Kurt Straif,et al.  A review of human carcinogens--part D: radiation. , 2009, The Lancet. Oncology.

[104]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[105]  A. Iafrate,et al.  Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers , 2012, Science Translational Medicine.

[106]  Robert A Gardiner,et al.  Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study , 2016, The Lancet.

[107]  G. Guy,et al.  Surgeon General’s Call to Action to Prevent Skin Cancer , 2014, Morbidity and Mortality Weekly Report.

[108]  Rebecca L Morgan,et al.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[109]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[110]  E. Emanuel,et al.  Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. , 2014, JAMA.

[111]  M. Dewhirst,et al.  Effects and potential mechanisms of exercise training on cancer progression: A translational perspective , 2013, Brain, Behavior, and Immunity.

[112]  S. Gettinger,et al.  First-line nivolumab (anti-PD-1; BMS-936558, ONO-4538) monotherapy in advanced NSCLC: Safety, efficacy, and correlation of outcomes with PD-L1 status. , 2014 .

[113]  Greta M. Massetti,et al.  Vital Signs: Melanoma Incidence and Mortality Trends and Projections — United States, 1982–2030 , 2015, MMWR. Morbidity and mortality weekly report.

[114]  David Goldstein,et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.

[115]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[116]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[117]  J. Hadler,et al.  Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions , 2013, Cancer.

[118]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[119]  Avrum Spira,et al.  Transforming Cancer Prevention through Precision Medicine and Immune-oncology , 2016, Cancer Prevention Research.

[120]  Ahmedin Jemal,et al.  Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer , 2016, Cancer.

[121]  S. Spechler,et al.  Barrett esophagus and risk of esophageal cancer: a clinical review. , 2013, JAMA.

[122]  Gregory Riely,et al.  EGFR: The Paradigm of an Oncogene-Driven Lung Cancer , 2015, Clinical Cancer Research.

[123]  Heather L. Mulder,et al.  Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. , 2014, The New England journal of medicine.

[124]  G. Linette,et al.  Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. , 2015, The New England journal of medicine.

[125]  Jessica Katz,et al.  Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma. , 2015, The New England journal of medicine.

[126]  G. Colditz,et al.  Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. , 2012, Annual review of public health.

[127]  Frances E. Thompson,et al.  Adults Meeting Fruit and Vegetable Intake Recommendations — United States, 2013 , 2015, MMWR. Morbidity and mortality weekly report.

[128]  K. Straif,et al.  A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. , 2009, The Lancet. Oncology.

[129]  F. Hecht,et al.  Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. , 2012, Journal of alternative and complementary medicine.

[130]  R. Herbst,et al.  Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement , 2013, Clinical Cancer Research.

[131]  D. Silverman,et al.  Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. , 2016, Journal of the National Cancer Institute.

[132]  Joakim Dillner,et al.  Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. , 2010, Journal of the National Cancer Institute.

[133]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[134]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.

[135]  D. Sargent,et al.  Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group Trial , 2007, Annals of surgery.

[136]  K. Schmitz,et al.  Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema , 2014, Journal of Cancer Survivorship.

[137]  R. Pangrazi,et al.  Step It Up , 2009 .

[138]  Jennifer A. Doudna,et al.  Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering , 2016, Cell.

[139]  P. Kantoff,et al.  Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.

[140]  H. Jessen,et al.  HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. , 2011, The New England journal of medicine.

[141]  J. Utikal,et al.  Improved survival with MEK inhibition in BRAF-mutated melanoma. , 2012, The New England journal of medicine.

[142]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[143]  Brian A. King,et al.  Tobacco Use Among Middle and High School Students--United States, 2011-2015. , 2016, MMWR. Morbidity and mortality weekly report.

[144]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[145]  Troy Guthrie,et al.  Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[146]  Kurt Straif,et al.  The carcinogenicity of outdoor air pollution. , 2013, The Lancet. Oncology.

[147]  S. Stokley,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014 , 2015, MMWR. Morbidity and mortality weekly report.

[148]  M. Fiore,et al.  Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research , 2016, Clinical Cancer Research.

[149]  S. el-Halabi,et al.  Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013. , 2015, MMWR. Morbidity and mortality weekly report.

[150]  F. Marincola,et al.  Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment , 2013, Science.

[151]  Manal M. Hassan,et al.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[152]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[153]  D. Dwyer,et al.  Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010. , 2011, MMWR. Morbidity and mortality weekly report.

[154]  J. Gribben,et al.  Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial. , 2016, The Lancet. Oncology.

[155]  T. Robak,et al.  New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies , 2011, BioDrugs.

[156]  R. Hicks,et al.  Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[157]  J. Lunceford,et al.  Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. , 2016, The Lancet. Oncology.

[158]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[159]  N. Mandel,et al.  Messages from the Food Police: How Food-Related Warnings Backfire among Dieters , 2015, Journal of the Association for Consumer Research.

[160]  E. Giovannucci,et al.  Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States. , 2016, JAMA oncology.

[161]  Richard E. Harris,et al.  Investigation of 2 Types of Self-administered Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors: A Randomized Clinical Trial. , 2016, JAMA oncology.

[162]  Jillian E. Schreiber,et al.  Update on Post‐mastectomy Lymphedema Management , 2016, The breast journal.

[163]  Noele P. Nelson,et al.  Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. , 2016, Morbidity and mortality weekly report. Surveillance summaries.

[164]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[165]  Mark T Hegel,et al.  Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[166]  Joanne S Haviland,et al.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. , 2013, The Lancet. Oncology.

[167]  J. Manyika.  Big data: The next frontier for innovation, competition, and productivity , 2011 .

[168]  B. Stewart,et al.  World cancer report 2014. , 2014 .

[169]  S. Gabriel,et al.  Genomic correlates of response to CTLA-4 blockade in metastatic melanoma , 2015, Science.

[170]  Antoni Ribas,et al.  Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.

[171]  Y. Im,et al.  Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[172]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[173]  Supriya G Mohile,et al.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[174]  P. Ascierto,et al.  Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. , 2014, The New England journal of medicine.

[175]  A. Fournier,et al.  Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. , 2016, JAMA internal medicine.

[176]  J. Cuzick,et al.  Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial , 2014, The Lancet.

[177]  J. Wolchok,et al.  Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[178]  Christian Pilarsky,et al.  Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. , 2009, Clinical chemistry.

[179]  J. T. Cox,et al.  Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening , 2004, Obstetrics and gynecology.

[180]  K. Flaherty,et al.  Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.

[181]  M. Socinski,et al.  Phase 2 prospective analysis of alectinib in ALK-positive, crizotinib-resistant non-small-cell lung cancer , 2015, The Lancet. Oncology.

[182]  P. Sasieni,et al.  13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010 , 2011, British Journal of Cancer.

[183]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[184]  E. Olsen,et al.  State indoor tanning laws and adolescent indoor tanning. , 2014, American journal of public health.

[185]  Michael Thomas,et al.  Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. , 2013, The New England journal of medicine.

[186]  Maria Bjurberg,et al.  Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients , 2003, Supportive Care in Cancer.

[187]  J. Wolchok,et al.  Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. , 2016, JAMA.

[188]  M. Kamdar,et al.  Early integrated palliative care to improve family caregivers (FC) outcomes for patients with gastrointestinal and lung cancer. , 2016 .

[189]  S. Habib,et al.  Diabetes and Risk of Cancer , 2013, ISRN oncology.

[190]  J. Larkin,et al.  Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial. , 2015, The Lancet. Oncology.

[191]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2001. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.

[192]  Yan-Shen Shan,et al.  Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial , 2016, The Lancet.

[193]  D. Lowy,et al.  Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial , 2013, Cancer Prevention Research.

[194]  C. Nanni,et al.  18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT , 2015, Clinical nuclear medicine.

[195]  W. Woodward,et al.  Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. , 2015, JAMA oncology.

[196]  Target Validation Team.  Dysregulated metabolism contributes to oncogenesis , 2015 .

[197]  Mellar P. Davis,et al.  A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. , 2015, Annals of palliative medicine.

[198]  Alona Muzikansky,et al.  Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.

[199]  Michael Hallek,et al.  Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. , 2014, The New England journal of medicine.

[200]  R. Jagsi,et al.  Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. , 2015, JAMA oncology.

[201]  Brian A. King,et al.  Vital Signs: Exposure to Electronic Cigarette Advertising Among Middle School and High School Students - United States, 2014. , 2016, MMWR. Morbidity and mortality weekly report.

[202]  G. Freeman,et al.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. , 2007, Immunity.

[203]  Parth D. Shah,et al.  Quality of Physician Communication about Human Papillomavirus Vaccine: Findings from a National Survey , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[204]  B. Pizacani,et al.  Demonstrating the importance and feasibility of including sexual orientation in public health surveys: health disparities in the Pacific Northwest. , 2010, American journal of public health.

[205]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[206]  Janet E. Fulton,et al.  Adult Participation in Aerobic and Muscle-Strengthening Physical Activities — United States, 2011 , 2013, MMWR. Morbidity and mortality weekly report.

[207]  J L Collins,et al.  Youth Risk Behavior Surveillance--United States, 1997. State and Local YRBSS Coordinators. , 1998, The Journal of school health.

[208]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.

[209]  G. Gordon,et al.  Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. , 2016, The Lancet. Oncology.

[210]  M. Greene,et al.  Concise handbook of familial cancer susceptibility syndromes - second edition. , 2008, Journal of the National Cancer Institute. Monographs.

[211]  G. Daniels,et al.  High dose (HD) IL-2 for metastatic renal cell carcinoma (mRCC) in the targeted therapy era: Extension of OS benefits beyond complete response (CR) and partial response (PR). , 2014 .

[212]  W. T. Vonstille,et al.  Radon and cancer , 1990 .

[213]  Kirsten Bibbins-Domingo,et al.  Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. , 2016, Annals of internal medicine.

[214]  M. Fine,et al.  Systematic Review and Meta-Analysis of Inhaled Toxicants from Waterpipe and Cigarette Smoking , 2016, Public health reports.

[215]  A. Giobbie-Hurder,et al.  Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. , 2014, The New England journal of medicine.

[216]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[217]  M. Hallek,et al.  Management of chronic lymphocytic leukemia , 2014, Haematologica.

[218]  Connie Lim,et al.  Youth Risk Behavior Surveillance - United States, 2015. , 2016, Morbidity and mortality weekly report. Surveillance summaries.

[219]  A. Hartman,et al.  The association between demographic and behavioral characteristics and sunburn among U.S. adults - National Health Interview Survey, 2010. , 2014, Preventive medicine.

[220]  Yi-Fang Chang,et al.  Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis. , 2015, Journal of alternative and complementary medicine.

[221]  Nikki A. Hawkins,et al.  Patterns of sunscreen use on the face and other exposed skin among US adults. , 2015, Journal of the American Academy of Dermatology.

[222]  Lindsey A. Torre,et al.  Cancer Facts & Figures for Hispanics/Latinos 2012-2014 , 2009 .

[223]  M. LeFevre.  Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement , 2014 .

[224]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[225]  R. Croyle,et al.  Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015 , 2016, Public health reports.

[226]  Wendy Leisenring,et al.  Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. , 2010, Journal of the National Cancer Institute.

[227]  P. Nathan,et al.  Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. , 2016, The New England journal of medicine.

[228]  Jennifer A. Hobin,et al.  Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology , 2015, Clinical Cancer Research.

[229]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[230]  A. Palumbo,et al.  Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. , 2016, The New England journal of medicine.

[231]  C. Wheeler,et al.  Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. , 2012, The Lancet. Oncology.

[232]  J. Haldane,et al.  The Genetics of Cancer , 1933, Nature.

[233]  Christopher S. Carpenter,et al.  Disparities in health insurance coverage, access, and outcomes for individuals in same-sex versus different-sex relationships, 2000-2007. , 2010, American journal of public health.

[234]  E. Feuer,et al.  Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000 , 2012, Journal of the National Cancer Institute.

[235]  G. Ioannou.  Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey , 2011, Annals of Internal Medicine.

[236]  C. Fuchs,et al.  Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.

[237]  Nina Bhardwaj,et al.  AACR Cancer Progress Report 2015 , 2015, Clinical Cancer Research.

[238]  B. Graubard,et al.  Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States , 2013, The American Journal of Gastroenterology.